Large-scale genomic surveillance reveals immunosuppression drives mutation dynamics in persistent SARS-CoV-2 infections

Publication date: Feb 13, 2025

Persistent SARS-CoV-2 infections have been hypothesized to play a key role in the emergence of variants of concern. However, the factors determining which individuals are at risk and their viral molecular signatures during infection remain poorly understood. Using the extensive COVID-19 surveillance database in Denmark, comprising over 700,000 genomes, we identified 303 persistent infections and, critically, linked them to health and sociodemographic data. Our analysis confirms the hypothesis that immunocompromised individuals are at the highest risk of experiencing persistent infections. Other disease groups associated with mortality, such as diabetes, showed no such associations. Among these persistent infections, the viral sequences exhibited signs of diversifying selection, with recurrent mutations linked to treatment resistance. Our findings suggest that immunosuppression plays a key role in the emergence of novelty in persistent infections.

PDF

Concepts Keywords
Danish Ba
Diabetes30 Cov
Genetic57 Cri
Immunosuppression Emergence
Inflammatory Individuals
Infection
Infections
Linked
Persistent
Preprint
Risk
Sars
Sequences
Surveillance
Viral

Semantics

Type Source Name
disease IDO immunosuppression
disease MESH SARS-CoV-2 infections
disease IDO role
disease MESH infection
disease MESH persistent infections
drug DRUGBANK Etodolac
disease MESH Infectious Diseases
drug DRUGBANK Aspartame
disease IDO pathogen
disease IDO history
disease IDO quality
disease MESH viral load
disease IDO process
drug DRUGBANK Methionine
disease MESH Comorbidity

Download Document

(Visited 1 times, 1 visits today)